Trinity Biotech Announces the Submission of TrinScreen™ HIV to the World Health Organisation for Approval
30 mars 2021 09h00 HE
|
Trinity Biotech plc
DUBLIN, Ireland, March 30, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has submitted its new HIV screening product, TrinScreen™ HIV, to the World Health Organisation (WHO) for...
Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results
25 mars 2021 09h28 HE
|
Trinity Biotech plc
DUBLIN, Ireland, March 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial Results
23 mars 2021 16h15 HE
|
Trinity Biotech plc
DUBLIN, Ireland, March 23, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
05 janv. 2021 08h04 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia™ SARS-CoV-2...
Trinity Biotech Announces Results for Q3, 2020
17 nov. 2020 09h12 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Third Quarter 2020 Financial Results
29 oct. 2020 10h38 HE
|
Trinity Biotech plc
DUBLIN, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
Trinity Biotech Announces Results for Q2, 2020
25 août 2020 09h40 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test
20 août 2020 10h31 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Second Quarter 2020 Financial Results
18 août 2020 08h04 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech subsidiary, Primus Corporation Receives FDA Warning Letter
17 août 2020 09h10 HE
|
Trinity Biotech plc
DUBLIN, Ireland, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...